Gian Luigi Ravetti
About
In The Last Decade
Gian Luigi Ravetti
8 papers receiving 565 citations
Peers
Comparison fields: 5 of 58
- Molecular Biology 380
- Oncology 233
- Cancer Research 198
- Genetics 154
- Epidemiology 47
Countries citing papers authored by Gian Luigi Ravetti
This map shows the geographic impact of Gian Luigi Ravetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gian Luigi Ravetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gian Luigi Ravetti more than expected).
Fields of papers citing papers by Gian Luigi Ravetti
This network shows the impact of papers produced by Gian Luigi Ravetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gian Luigi Ravetti. The network helps show where Gian Luigi Ravetti may publish in the future.
Co-authorship network of co-authors of Gian Luigi Ravetti
This figure shows the co-authorship network connecting the top 25 collaborators of Gian Luigi Ravetti. A scholar is included among the top collaborators of Gian Luigi Ravetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gian Luigi Ravetti. Gian Luigi Ravetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 3 | |
| 3 | Renal Leiomyosarcoma. A Report of Two Cases. | 3 |
| 4 | 32 | |
| 5 | 37 | |
| 6 | Patients with systemic lupus erythematosus (SLE) having developed malignant lymphomas. Complete remission of lymphoma following high-dose chemotherapy, but not of SLE. | 4 |
| 7 | 481 | |
| 8 | Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis. | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.